Surgery – Instruments – Cyrogenic application
Reexamination Certificate
2001-12-18
2004-03-23
Peffley, Michael (Department: 3739)
Surgery
Instruments
Cyrogenic application
C606S020000
Reexamination Certificate
active
06709431
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention pertains generally to the field of cryo therapy. More particularly, the present invention pertains to cryo balloon therapy catheters for use in causing cold-induced necrosis.
2. Description of the Related Art
A number of medical conditions may be treated using ablative techniques or devices. Ablative techniques, generally, result in the necrosis of abnormal tissue at an area of interest. Ablation of the abnormal tissue may result in an efficacious treatment for a medical condition. For example, atrial fibrillation may be the result of abnormal electrical activity in the left atrium and the pulmonary vein, and may be treatable by ablation of the abnormal tissue within the left atrium and/or the pulmonary vein.
A trial fibrillation is a serious medical condition that is the result of abnormal electrical activity within the heart. This abnormal activity may occur at regions of the heart including the sino-atrial (SA) node, the atriovenricular (AV) node, the bundle of His, or within other areas of cardiac tissue. Moreover, atrial fibrillation may be caused by abnormal activity within a isolated focal center within the heart. It is believed that these foci can originate within the pulmonary vein, particularly the superior pulmonary veins.
Minimally invasive techniques have been described that use ablation catheters to target the pulmonary vein with the hope of ablating foci having abnormal electrical activity. The techniques typically are characterized by application of energy to cause lesions within the foci or other areas possessing abnormal electrical activity.
Some ablation devices utilize radio frequency (RF) energy for ablation, including the device disclosed in U.S. Pat. No. 6,024,740 to Lesh et al. The RF energy devices may be used to ablate an area of interest with heat. The use of RF energy for ablation may, however, lead to untoward healing responses such as collagen build up at the area of interest after treatment. Moreover, RF ablation of within an atrium may decrease atrial output. A need, therefore, exists for ablative devices and methods that include improved healing responses.
An alternative treatment strategy has been developed that uses cooling energy for. ablation. This method, termed cryoplasty or cryo balloon therapy, may be used to cool the lesion to freeze a portion of the affected area. For example, cryo balloon therapy may be used to freeze a lesion within a blood vessel that might otherwise lead to restenosis or recoil.
In addition to its potential utility in preventing and slowing restenosis and addressing recoil, cryo balloon therapy may be used for ablation techniques. For example, cryo balloon therapy may be efficacious in varicose vein treatment of incompetent valves, valvular disease, mitral valve regurgitation therapy, atrial fibrillation, gastric reflux disease, gastro esophageal reflux disease, GURD, esophageal disease, cancer treatment including stomach or uterine cancer, etc.
Uses of cryo balloon therapy include cold-induced necrosis of cells within the body. When the target area is located within the heart or pulmonary vasculature, it may be important to precisely control the cryo balloon therapy catheter to necrosis only the desired tissue. Precise temperature regulation may be required to necrosis target tissues while minimizing damage to healthy tissue. Moreover, precise temperature monitoring may be useful in target areas that have an uneven surface, such as trabeculae within the heart. A need, therefore, exists for cryoplasty catheters with precise temperature monitoring capabilities.
BRIEF SUMMARY OF THE INVENTION
The present invention pertains to a refinement to cryo therapy catheters that may incorporate some of the needs described above. More particularly, the present invention comprises a temperature monitoring device for use with a cryo balloon therapy catheters. The temperature monitoring device may be coupled to a cryo therapy catheter and may be used to measure temperature while performing a medical procedure, for example cryo balloon therapy or cryoplasty. The temperature monitoring device may comprise a tubular member having a temperature monitoring member coupled thereto.
The temperature monitoring member may comprise a retractable needle slidably disposed within a lumen of the tubular member. Alternatively, the temperature monitoring member comprises an infrared optic sensor, an ultrasound transmitter, or a sheath that encircles the cryo therapy apparatus having a plurality of thermal spikes. In addition, one or more tubular members may be disposed about the cryo therapy apparatus in an array.
REFERENCES:
patent: 3125096 (1964-03-01), Antiles et al.
patent: 4784133 (1988-11-01), Mackin
patent: 4860744 (1989-08-01), Johnson et al.
patent: 5019042 (1991-05-01), Sahota
patent: 5057106 (1991-10-01), Kasevich et al.
patent: 5078713 (1992-01-01), Varney
patent: 5108390 (1992-04-01), Potocky et al.
patent: 5139496 (1992-08-01), Hed
patent: 5147355 (1992-09-01), Friedman et al.
patent: 5190540 (1993-03-01), Lee
patent: 5220927 (1993-06-01), Astrahan et al.
patent: 5281215 (1994-01-01), Milder
patent: 5334181 (1994-08-01), Rubinsky et al.
patent: 5334193 (1994-08-01), Nardella
patent: 5335669 (1994-08-01), Tilson et al.
patent: 5342301 (1994-08-01), Saab
patent: 5417689 (1995-05-01), Fine
patent: 5423807 (1995-06-01), Milder
patent: 5443470 (1995-08-01), Stern et al.
patent: 5454807 (1995-10-01), Lennox et al.
patent: 5501681 (1996-03-01), Neuwirth et al.
patent: 5520682 (1996-05-01), Baust et al.
patent: 5536252 (1996-07-01), Imran et al.
patent: 5562720 (1996-10-01), Stern et al.
patent: 5624392 (1997-04-01), Saab
patent: 5674218 (1997-10-01), Rubinsky et al.
patent: 5733319 (1998-03-01), Neilson et al.
patent: 5807391 (1998-09-01), Wijkamp
patent: 5868735 (1999-02-01), Lafontaine
patent: 5957917 (1999-09-01), Dolron et al.
patent: 5971979 (1999-10-01), Joye et al.
patent: 6012457 (2000-01-01), Lesh
patent: 6024740 (2000-02-01), Lesh et al.
patent: 6190378 (2001-02-01), Jarvinen
patent: 6193644 (2001-02-01), Dobak, III et al.
patent: 6283959 (2001-09-01), Lalonde et al.
patent: 6290696 (2001-09-01), Lafontaine
patent: 6355029 (2002-03-01), Joye et al.
patent: 6405732 (2002-06-01), Edwards et al.
patent: 197 24 082 (1998-12-01), None
patent: 2 403 063 (1979-04-01), None
patent: 1019028 (1966-02-01), None
patent: WO 0047118 (2000-08-01), None
patent: WO 00/47118 (2000-08-01), None
patent: WO 00/47121 (2000-08-01), None
patent: WO 01/22897 (2001-04-01), None
A. Schilling et al., “Nature of the Vehicle for Cryopreservation of Human Peripheral Veins: Preservation of Reactivity to Pharmacological Stimuli”,Cryobiology32, 109-113 (1995).
P. Nataf et al., “Effect of Cold Anoxia and Cryopreservation on Metabolic and Contractile Functions of Human Mammary Artery”,Cryobiology, 32, 327-333 (1995).
Mazur, P., Physical-Chemical Factors Underlying Cell Injury in Cryosurgical Freezing,Cryosurgery, pp. 32-51, published on date even with or prior to Jan. 12, 1999.
Cahan, W., “Five Years of Cryosurgical Experience: Benign and Malignant Tumors with Hemorrhagic Conditions”,Cryosurgery, pp. 388-391, published on date even with or prior to Jan. 12, 1999.
Zacarian, S., “Cryosurgery of Tumors of the Skin and Oral Cavity”, 5 pages, published on date even with or prior to Jan. 12, 1999.
B. Fuller et al., “Clinical Applications of Cryobiology”, 4 pages, published on date even with or prior to Jan. 12, 1999.
G. Morris et al., “Effects of Low Temperatures on Biological Membranes”, 2 pages, published on date even with or prior to Jan. 12, 1999.
R. Coger et al., “Preservation Techniques for Biomaterials”,The Biomedical Engineering Handbook, 8 pages, 1995.
C. Hunt et al., “Fractures in Cryopreserved Arteries”,Cryobiology, 31, 506-515 (1994).
Article entitled “Prostate Cryosurgery now Reimbursable in Southern California”,Healthcare Technology Management, published on date even with or prior to Jan. 12, 1999, 1 page.
Abstract entitled “Renal Cryoablation in a Canine Model”,Urology, May 1996
Fish & Richardson P.C. P.A.
Peffley Michael
Vrettakos Peter
LandOfFree
Cryo-temperature monitoring does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cryo-temperature monitoring, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cryo-temperature monitoring will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3204263